STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 10th, 2023 • Camac Fund, LP • Pharmaceutical preparations • New York
This Stock Purchase Agreement (this “Agreement”), dated as of December 21st, 2022, is entered into among Concord IP2 Ltd., Elderhill Corporation, Leonite Capital LLC, Leonite Fund I, LP, Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, David Delaney, Avi Geller, and Eric Shahinian (each a “Seller” and collectively the “Sellers”), and Pasithea Therapeutics Corp. (the “Buyer” or the “Company”). Capitalized terms used in this Agreement have the meanings given to such terms herein.
